ArticleJournal of cancer survivorship : research and practice2025
Characterizing surveillance-associated anxiety following curative-intent surgery for gastrointestinal cancer: a mixed methods approach.
Article in Journal of cancer survivorship : research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeImaging is often an essential component of cancer surveillance following curative-intent surgery but can be distressing for some patients. While this phenomenon has been studied among patients undergoing active cancer treatment and screening, the frequency and severity of "scanxiety" among patients undergoing surveillance after curative-intent cancer surgery is poorly understood.
methodsA cross-sectional mixed-methods analysis of patients with a history of resected gastrointestinal (GI) or hepatopancreatobiliary (HPB) cancer undergoing routine cancer surveillance was conducted. After their imaging was completed but before meeting with their provider, patients completed the Impact of Events Scale-revised (IES-r) and the Hospital Anxiety and Depression Scale (HADS) anxiety subscale surveys. IES-r and HADS-anxiety scores ≥ 24 (scale 0-88) and ≥ 11 (scale 0-22), respectively, were considered clinically meaningful. Semi-structured interviews were conducted among a convenience sample of patients, which were subsequently transcribed and then coded using an inductive approach.
resultsAmong 101 participants, mean age was 62 ± 13.9 years old and 52% were male. The most common diagnoses were cancers of the pancreas (23.8%), appendix (20.8%), and colon & rectum (20.8%). Mean time since surgery was 30.7 ± 28.0 months. Overall IES-r and HADS scores were 12.1 ± 14.7 and 5.2 ± 4.7, respectively. On multivariable linear regression analysis, a previous mental health diagnosis was associated with increased HADS, total IES, and all IES subscale scores whereas older age was associated with lower HADS and total IES scores (all p < 0.05). African American race, public insurance, and longer distance traveled were associated with increased IES hyperarousal scores. Qualitative analysis highlighted the psychological symptoms associated with surveillance imaging, its impact on daily living, and primary coping strategies.
conclusionsIn this cross-sectional study of patients with resected GI and HPB cancers, symptoms of anxiety and post-traumatic stress around the time of routine cancer surveillance were common but relatively mild. A prior mental health diagnosis and younger age may be risk factors for greater symptomatology. IMPLICATIONS FOR CANCER SURVIVORS: Future research should work to identify which patients are at highest risk for surveillance-associated anxiety so that patient-centered interventions can be designed and studied in this growing patient population.
Indexed as
Identifiers
40299240What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.